Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 21, 2012; 18(19): 2344-2356
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2344
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2344
Groups | Experimental design |
Healthy control | No DSS treatments |
Negative control (saline) | 5% (w/v) DSS dissolved in drinking water for 7 d |
Saline administered intragastrically once daily for 9 d | |
Positive control (5-ASA) | 5% (w/v) DSS dissolved in drinking water for 7 d |
5-ASA administered intragastrically once daily for 9 d | |
Investigating group (CCTCC M206119) | 5% (w/v) DSS dissolved in drinking water for 7 d |
CCTCC M206119 administered intragastrically once daily for 9 d |
-
Citation: Zhou FX, Chen L, Liu XW, Ouyang CH, Wu XP, Wang XH, Wang CL, Lu FG.
Lactobacillus crispatus M206119 exacerbates murine DSS-colitis by interfering with inflammatory responses. World J Gastroenterol 2012; 18(19): 2344-2356 - URL: https://www.wjgnet.com/1007-9327/full/v18/i19/2344.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i19.2344